Page 12 - Arix Bioscience News Today

Investegate announcements from Arix Bioscience PLC, Director/PDMR Shareholding

Investegate announcements from Arix Bioscience PLC, Unaudited NAV for August 2022

Aristea Therapeutics Strengthens its Board of Directors with the Appointment of Three Accomplished Biopharma Leaders From Poseida Therapeutics, Novo Holdings and Pfizer - read this article along with other careers information, tips and advice on BioSpace

11.08.2022 - Acacia Research Corporation (Nasdaq: ACTG) (“Acacia” or the “Company”) today reported financial results for the three and six months ended June 30, 2022. Key Business Highlights Generated $16.7 million in consolidated revenue for the quarter, down ...

Investegate announcements from Arix Bioscience PLC, Arix Bioscience plc Announces Changes to Board of Directors

DJ Arix Bioscience plc Announces Changes to Board of Directors Arix Bioscience PLC (ARIX) Arix Bioscience plc Announces Changes to Board of Directors 10-Aug-2022 / 07:01 GMT/BST Dissemination of

10.08.2022 - Gemini Therapeutics, Inc. (Nasdaq: GMTX) (“Gemini”) and Disc Medicine, Inc. (“Disc”), a privately-held, clinical-stage biopharmaceutical company focused on the discovery and development of novel treatments for patients suffering from serious ... Seite 1

Gemini Therapeutics (GMTX) is merging with privately held Disc Medicine in an all-stock transaction.The combined company — which will be headquarters in Watertown, Massachusetts — will...

Arix Bioscience PLC (ARIX) Artios initiates Phase 2 study of Pol Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BR...

Investegate announcements from Arix Bioscience PLC, Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics